Market & Forensics Analyst, Beat the Street

Nimish Maheshwari

Nimish Maheshwari, an independent analyst and co-founder of Beat The Street, is an investing platform garnering more than 1,00,000+ followers across social media. 
His deep insights and forensic analysis have been featured in some of India's most prominent publications, including the Economic Times, The Morning Context, The Ken,  Dalal Street Investment Journal, Moneylife by Sucheta Dalal, and TheCore.in.
He has a keen eye for identifying red flags in Indian listed companies and has identified exclusive red flags earlier in Adani, Vedanta, Nykaa, Gland Pharma, Brightcom Group etc.

Market & Forensics Analyst

Nephrocare Health Services: Exporting India’s Dialysis Operating Model

SEMICON India 2026 Review: Key Announcements

India's Defence Opportunity Is Shifting From Platforms To Technology

Pine Labs: Profitability Has Arrived, But Is It Sustainable?

Paytm: The Turnaround Is Now an Earnings-Compounding Story

Why Foreign Strategic Inflows Can Reprice Indian Banks and NBFCs?

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Thematic (Sector/Industry)

India Financials / Thematic (Sector/Industry)

<ul>
<li>The 0.4% MDR is not pure fintech revenue. Exemptions, fee-sharing, merchant behaviour and competitive incentives will determine how much reaches profits.</li>
<li>Paytm is the strongest listed beneficiary: Its presence across consumer UPI and merchant acquiring allows it to earn from both sides of eligible transactions.</li>
<li>Pine Labs, MobiKwik benefit differently: Pine Labs gains through merchant acquiring, while MobiKwik’s upside depends on scaling UPI volumes and merchant transactions.</li>
</ul>


The 0.4% MDR is not pure fintech revenue. Exemptions, fee-sharing, merchant behaviour and competitive incentives will determine how much reaches profits.
Paytm is the strongest listed beneficiary: Its presence across consumer UPI and merchant acquiring allows it to earn from both sides of eligible transactions.
Pine Labs, MobiKwik benefit differently: Pine Labs gains through merchant acquiring, while MobiKwik’s upside depends on scaling UPI volumes and merchant transactions.


How MDR Will Impact Paytm, Pinelabs, MobiKwik?